Ratings and Reviews 0 Ratings

Total
ease
features
design
support

This software has no reviews. Be the first to write a review.

Write a Review

Ratings and Reviews 0 Ratings

Total
ease
features
design
support

This software has no reviews. Be the first to write a review.

Write a Review

Alternatives to Consider

  • Opus Reviews & Ratings
    93 Ratings
    Company Website
  • RXNT Reviews & Ratings
    549 Ratings
    Company Website
  • DoctorConnect Reviews & Ratings
    83 Ratings
    Company Website
  • AdvancedMD Reviews & Ratings
    2 Ratings
    Company Website
  • Modento Reviews & Ratings
    89 Ratings
    Company Website
  • Service Center Reviews & Ratings
    122 Ratings
    Company Website
  • Medsender Reviews & Ratings
    28 Ratings
    Company Website
  • Valant Behavioral Health EHR Reviews & Ratings
    335 Ratings
    Company Website
  • Robin by Atera Reviews & Ratings
    519 Ratings
    Company Website
  • FrameworkLTC Reviews & Ratings
    48 Ratings
    Company Website

What is IPM.ai?

Specialty and rare diseases frequently involve patient groups that are ambiguously defined, including those who are undiagnosed or improperly diagnosed, as well as healthcare professionals who might be uninformed about these disorders and their diverse presentations, leading to treatment pathways that lack clarity. IPM.ai functions as an Insights-as-a-Service (IaaS) organization, committed to equipping prominent life sciences companies with profound insights into patient care, thereby improving the quality of life for affected individuals via the advancement, clinical investigation, and marketing of therapeutic options. By forecasting market dimensions, scrutinizing the competitive environment, and assessing potential returns on investment, businesses can refine their commercialization tactics effectively. In addition, the platform plays a crucial role in recognizing undiagnosed or misdiagnosed patients who could gain from early intervention and therapeutic solutions. It utilizes statistical methodologies to evaluate the occurrence of particular diseases among specific patient demographics at any time. Moreover, IPM.ai aids in identifying physicians who excel in diagnosing and treating these optimal patients, while also motivating other healthcare practitioners to improve overall patient outcomes. This all-encompassing strategy ultimately seeks to close the gap in understanding and addressing the requirements of individuals with rare diseases, ensuring they receive the attention and care they deserve. By fostering collaboration among healthcare providers, IPM.ai aims to create a more informed and responsive healthcare ecosystem.

What is Artrya?

Artrya partners with clinics that focus on patients with chest pain to pioneer advanced AI-driven cardiovascular care models. This collaboration facilitates the integration of high-prognostic value plaque characteristics into the evaluation of coronary artery disease. In both emergency and primary care settings, swift assessments of chest pain patients become achievable. We foresee a future where heart attack occurrences within communities are drastically diminished. By leveraging AI insights from coronary computed tomography angiography (CCTA), healthcare providers can quickly categorize chest pain patients within minutes, based on the type and volume of arterial plaque identified. This innovative technology allows for the prompt detection of individuals with minimal or no coronary artery disease, ensuring that no concealed plaque characteristics are overlooked that could potentially lead to severe cardiac incidents in the future. Identifying early signs of a possible heart attack is of utmost importance. Furthermore, this method enables the effective identification of patients at risk who present with acute or atypical chest pain, guaranteeing they receive appropriate further evaluation and treatment. By adopting this proactive approach, not only are patient outcomes improved, but the overall health of the community is also enhanced, fostering a culture of preventive care. The ongoing commitment to integrating cutting-edge technology will continue to transform cardiovascular care for the better.

Media

Media

Integrations Supported

Additional information not provided

Integrations Supported

Additional information not provided

API Availability

Has API

API Availability

Has API

Pricing Information

Pricing not provided.
Free Trial Offered?
Free Version

Pricing Information

Pricing not provided.
Free Trial Offered?
Free Version

Supported Platforms

SaaS
Android
iPhone
iPad
Windows
Mac
On-Prem
Chromebook
Linux

Supported Platforms

SaaS
Android
iPhone
iPad
Windows
Mac
On-Prem
Chromebook
Linux

Customer Service / Support

Standard Support
24 Hour Support
Web-Based Support

Customer Service / Support

Standard Support
24 Hour Support
Web-Based Support

Training Options

Documentation Hub
Webinars
Online Training
On-Site Training

Training Options

Documentation Hub
Webinars
Online Training
On-Site Training

Company Facts

Organization Name

IPM.ai

Company Location

United States

Company Website

www.ipm.ai/platform

Company Facts

Organization Name

Artrya

Company Location

Australia

Company Website

www.artrya.com

Categories and Features

Categories and Features

Popular Alternatives

Popular Alternatives